Skip to content
10-Q

Quarterly Report

Avant Diagnostics, Inc

0001493152-18-018046

← back to feed
Filed
Dec 28, 2018 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2018 · Nov 15, 2018 336.96M sh
Cash And Equivalents Q1 2018 · Dec 31, 2017 $50.97K
Cash And Equivalents Q1 2018 · Sep 30, 2017 $1.35K
Cash And Equivalents Q1 2018 · Dec 31, 2016 $73.74K
Cash And Equivalents Q1 2018 · Sep 30, 2016 $851
Stockholders Equity Q1 2018 · Dec 31, 2017 $768.18K
Stockholders Equity Q1 2018 · Sep 30, 2017 $976.28K
Current Liabilities Q1 2018 · Dec 31, 2017 $4.38M
Current Liabilities Q1 2018 · Sep 30, 2017 $4.25M
Total Liabilities Q1 2018 · Dec 31, 2017 $4.38M
Total Liabilities Q1 2018 · Sep 30, 2017 $4.25M
Current Assets Q1 2018 · Dec 31, 2017 $50.97K
Current Assets Q1 2018 · Sep 30, 2017 $1.35K
Total Assets Q1 2018 · Dec 31, 2017 $5.15M
Total Assets Q1 2018 · Sep 30, 2017 $5.23M
Operating Cash Flow Q1 2018 · Dec 31, 2016 $501.2K
Sga Expense Q1 2018 · Dec 31, 2016 $443.29K
Net Income Q1 2018 · Dec 31, 2016 −$6.09M
Operating Income Q1 2018 · Dec 31, 2016 −$5.03M
Gross Profit Q1 2018 · Dec 31, 2016 $219.06K
Cost Of Revenue Q1 2018 · Dec 31, 2016 $22.96K
Revenue Q1 2018 · Dec 31, 2016 $242.02K